GlassScriptPhysician profile
Keith Alan Jarbo
NPI 1841510898
$16,398.11
in general payments reported to CMS, 2019-2025
21 companies · $1,289 in 2025
The $1,289 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,897 · 2020: $689 · 2021: $779 · 2022: $8,495 · 2023: $685 · 2024: $564 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,538.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $5,472.71 | 2021-2025 | Integrity Implant |
| Arthrosurface Incorporated | $4,233.83 | 2019-2020 | |
| Impactortho, INC. | $1,333.04 | 2022-2025 | |
| Medacta USA, INC. | $1,171.26 | 2022 | |
| Stryker Corporation | $944.30 | 2021-2025 | Gamma, Aequalis Perform Reversed, Tornier Perform Reversed Augmented Glenoid |
| Depuy Synthes Sales INC. | $913.08 | 2019-2025 | Truespan Orthocord, Attune, Inhance |
| Zimmer Biomet Holdings, INC. | $619.96 | 2019-2025 | Juggerknotless Soft Anchor, Tricera Handpiece |
| Arthrex, INC. | $603.03 | 2022 | |
| Vericel Corporation | $440.13 | 2019-2025 | Maci |
| Smith+Nephew, INC. | $238.00 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System |
| Abbott Laboratories | $182.92 | 2019-2025 | Proclaim |
| Orthofix Medical, INC. | $47.94 | 2021-2025 | Physio-Stim |
| Ethicon US, LLC | $46.40 | 2019-2021 | |
| Bioventus LLC | $29.25 | 2025 | Exogen Ultrasound Bone Healing System |
| Si-Bone, INC. | $27.98 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $19.73 | 2019 | |
| Endo Pharmaceuticals INC. | $15.99 | 2019 | |
| Axogen | $15.95 | 2023 | Avance Nerve Graft |
| Olympus America INC. | $14.88 | 2022 | |
| Kuros Biosciences USA, INC | $14.49 | 2025 | Magnetos |
| Kowa Pharmaceuticals America, INC. | $13.24 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Jarbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.